ZAFGEN, INC.·4

Feb 23, 5:06 PM ET

KIM DENNIS D 4

4 · ZAFGEN, INC. · Filed Feb 23, 2018

Insider Transaction Report

Form 4
Period: 2018-02-22
KIM DENNIS D
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-02-22+125,000125,000 total
    Exercise: $7.77Exp: 2028-02-22Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]25% of this option vests on February 22, 2019, and the remainder vests in equal monthly installments thereafter over 36 months

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION